Literature DB >> 16368496

Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases.

Daria Zorzi1, John T Mullen, Eddie K Abdalla, Timothy M Pawlik, Axel Andres, Andrea Muratore, Steven A Curley, Gilles Mentha, Lorenzo Capussotti, Jean-Nicolas Vauthey.   

Abstract

Some investigators have suggested that wedge resection (WR) confers a higher incidence of positive margins and an inferior survival compared with anatomic resection (AR) of colorectal liver metastases (CLM). We sought to investigate the margin status, pattern of recurrence, and overall survival of patients with CLM treated with WR or AR. We identified 253 consecutive patients, in a multi-institutional database from 1991 to 2004, who underwent either WR or AR. WR was defined as a nonanatomic resection of the CLM, and AR was defined as single or multiple resections of one or two contiguous Couinaud segments. Clinicopathologic factors were analyzed with regard to pattern of recurrence and survival. One hundred six WRs were performed in 72 patients and 194 ARs in 181 patients. There was no difference in the rate of positive surgical margin (8.3%), overall recurrence rates, or patterns of recurrence between patients treated with WR vs. AR. Patients who had a positive surgical resection margin were more likely to recur at the surgical margin regardless of whether they underwent WR or AR. The median survival was 76.6 months for WR and 80.8 months for AR, with 5-year actuarial survival rates of 61% and 60%, respectively. AR is not superior to WR in terms of tumor clearance, pattern of recurrence, or survival. WR should remain an integral component of the surgical treatment of CLM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368496     DOI: 10.1016/j.gassur.2005.07.022

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  46 in total

1.  Hepatic resection without mortality at a community hospital.

Authors:  Katsuhiko Yanaga; Kenzo Wakasugi; Toshimitsu Matsusaka; Hiroyuki Kume
Journal:  Int Surg       Date:  2003 Apr-Jun

2.  Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.

Authors:  David C Madoff; Eddie K Abdalla; Sanjay Gupta; Tsung-Teh Wu; Jeffrey S Morris; Alban Denys; Michael J Wallace; Frank A Morello; Kamran Ahrar; Ravi Murthy; Simon Lunagomez; Marshall E Hicks; Jean-Nicolas Vauthey
Journal:  J Vasc Interv Radiol       Date:  2005-02       Impact factor: 3.464

3.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

4.  Hepatic resection for metastatic colorectal cancer results in cure for some patients.

Authors:  R L Jamison; J H Donohue; D M Nagorney; C B Rosen; W S Harmsen; D M Ilstrup
Journal:  Arch Surg       Date:  1997-05

5.  Resection of colorectal liver metastases: 25-year experience.

Authors:  B Ohlsson; U Stenram; K G Tranberg
Journal:  World J Surg       Date:  1998-03       Impact factor: 3.352

6.  Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma.

Authors:  N Kokudo; K Tada; M Seki; H Ohta; K Azekura; M Ueno; T Matsubara; T Takahashi; T Nakajima; T Muto
Journal:  Am J Surg       Date:  2001-02       Impact factor: 2.565

7.  Aggressive surgical approach to recurrent tumors after hepatectomy for metastatic spread of colorectal cancer to the liver.

Authors:  H Imamura; S Kawasaki; S Miyagawa; T Ikegami; H Kitamura; R Shimada
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

8.  Resection of liver metastases from colorectal cancer: are there any truly significant clinical prognosticators?

Authors:  J Y Wang; J M Chiang; L B Jeng; C R Changchien; J S Chen; K C Hsu
Journal:  Dis Colon Rectum       Date:  1996-08       Impact factor: 4.585

9.  First and repeat resection of colorectal liver metastases in elderly patients.

Authors:  Thomas Zacharias; Daniel Jaeck; Elie Oussoultzoglou; Philippe Bachellier; Jean-Christophe Weber
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

10.  Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

Authors:  Eddie K Abdalla; Jean-Nicolas Vauthey; Lee M Ellis; Vickie Ellis; Raphael Pollock; Kristine R Broglio; Kenneth Hess; Steven A Curley
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  46 in total

Review 1.  Current treatment for colorectal liver metastases.

Authors:  Evangelos P Misiakos; Nikolaos P Karidis; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

Review 2.  Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome.

Authors:  George A Poultsides; Richard D Schulick; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

Review 3.  [Colorectal liver metastases. Neoadjuvant chemotherapy: aspects of medical and surgical oncology].

Authors:  Anke C Reinacher-Schick; W O Bechstein
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

Review 4.  Curable metastatic colorectal cancer: recommended paradigms.

Authors:  Richard N Berri; Eddie K Abdalla
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

Review 5.  Parenchymal-sparing liver surgery in patients with colorectal carcinoma liver metastases.

Authors:  Fernando A Alvarez; Rodrigo Sanchez Claria; Sebastian Oggero; Eduardo de Santibañes
Journal:  World J Gastrointest Surg       Date:  2016-06-27

6.  Management of colorectal liver metastases: past, present, and future.

Authors:  Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Updates Surg       Date:  2011-03

Review 7.  Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review.

Authors:  Dimitrios Moris; Sean Ronnekleiv-Kelly; Amir A Rahnemai-Azar; Evangelos Felekouras; Mary Dillhoff; Carl Schmidt; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-03-31       Impact factor: 3.452

8.  Liver resection for colorectal liver metastases with peri-operative chemotherapy: oncological results of R1 resections.

Authors:  Clarisse Eveno; Mehdi Karoui; Etienne Gayat; Alain Luciani; Marie-Luce Auriault; Michael D Kluger; Isabelle Baumgaertner; Laurence Baranes; Alexis Laurent; Claude Tayar; Daniel Azoulay; Daniel Cherqui
Journal:  HPB (Oxford)       Date:  2012-10-22       Impact factor: 3.647

Review 9.  Multisciplinary management of patients with liver metastasis from colorectal cancer.

Authors:  Kathleen De Greef; Christian Rolfo; Antonio Russo; Thiery Chapelle; Giuseppe Bronte; Francesco Passiglia; Andreia Coelho; Konstantinos Papadimitriou; Marc Peeters
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

10.  Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.

Authors:  Robert Cg Martin; Ken Robbins; Dana Tomalty; Ryan O'Hara; Petar Bosnjakovic; Radek Padr; Miloslav Rocek; Frantisek Slauf; Alexander Scupchenko; Cliff Tatum
Journal:  World J Surg Oncol       Date:  2009-11-03       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.